Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)
China
· Delayed Price · Currency is CNY 10.45
+0.12 (1.16%)
At close: Mar 10, 2026
SHA:600267 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 12,155 | 9,700 | 11,133 | 12,936 | 16,732 | 15,960 | Upgrade
|
| Market Cap Growth | 17.25% | -12.87% | -13.94% | -22.69% | 4.84% | 66.80% | Upgrade
|
| Enterprise Value | 14,290 | 13,151 | 15,743 | 18,163 | 23,563 | 24,129 | Upgrade
|
| Last Close Price | 10.45 | 8.10 | 9.14 | 10.61 | 13.34 | 15.70 | Upgrade
|
| PE Ratio | 22.02 | 16.14 | - | 26.46 | 34.37 | 38.26 | Upgrade
|
| Forward PE | 24.59 | 160.67 | 160.67 | 160.67 | 160.67 | 160.67 | Upgrade
|
| PS Ratio | 1.24 | 0.99 | 1.07 | 1.08 | 1.38 | 1.41 | Upgrade
|
| PB Ratio | 1.39 | 1.13 | 1.33 | 1.55 | 2.28 | 1.93 | Upgrade
|
| P/TBV Ratio | 1.59 | 1.31 | 1.58 | 1.92 | 2.84 | 2.69 | Upgrade
|
| P/FCF Ratio | 6.18 | 5.17 | 8.82 | 8.43 | 15.02 | 17.78 | Upgrade
|
| P/OCF Ratio | 5.28 | 4.59 | 7.41 | 6.26 | 9.64 | 10.04 | Upgrade
|
| EV/Sales Ratio | 1.45 | 1.34 | 1.52 | 1.51 | 1.94 | 2.13 | Upgrade
|
| EV/EBITDA Ratio | 7.29 | 7.67 | 11.64 | 9.15 | 13.11 | 13.08 | Upgrade
|
| EV/EBIT Ratio | 16.68 | 20.33 | 49.73 | 18.99 | 27.55 | 24.85 | Upgrade
|
| EV/FCF Ratio | 7.27 | 7.01 | 12.47 | 11.83 | 21.15 | 26.88 | Upgrade
|
| Debt / Equity Ratio | 0.39 | 0.48 | 0.67 | 0.77 | 1.07 | 0.99 | Upgrade
|
| Debt / EBITDA Ratio | 1.74 | 2.40 | 4.11 | 3.22 | 4.35 | 4.43 | Upgrade
|
| Debt / FCF Ratio | 1.73 | 2.21 | 4.45 | 4.18 | 7.05 | 9.10 | Upgrade
|
| Net Debt / Equity Ratio | 0.22 | 0.31 | 0.48 | 0.60 | 0.89 | 0.74 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.97 | 1.55 | 2.98 | 2.53 | 3.65 | 3.31 | Upgrade
|
| Net Debt / FCF Ratio | 0.96 | 1.41 | 3.19 | 3.27 | 5.89 | 6.81 | Upgrade
|
| Asset Turnover | 0.62 | 0.58 | 0.57 | 0.63 | 0.60 | 0.54 | Upgrade
|
| Inventory Turnover | 3.15 | 3.01 | 3.28 | 3.62 | 3.20 | 2.89 | Upgrade
|
| Quick Ratio | 0.61 | 0.59 | 0.62 | 0.59 | 0.45 | 0.41 | Upgrade
|
| Current Ratio | 0.95 | 0.92 | 0.97 | 0.90 | 0.72 | 0.70 | Upgrade
|
| Return on Equity (ROE) | 6.37% | 6.99% | -1.16% | 6.27% | 6.55% | 9.07% | Upgrade
|
| Return on Assets (ROA) | 3.39% | 2.41% | 1.09% | 3.13% | 2.66% | 2.87% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.05% | 4.51% | 2.46% | 5.04% | 4.80% | 5.18% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.10% | 6.60% | 2.90% | 8.20% | 8.10% | 9.40% | Upgrade
|
| Earnings Yield | 4.50% | 6.20% | -0.84% | 3.78% | 2.91% | 2.61% | Upgrade
|
| FCF Yield | 16.18% | 19.34% | 11.34% | 11.87% | 6.66% | 5.62% | Upgrade
|
| Dividend Yield | 2.03% | 2.59% | - | 1.60% | 1.05% | 0.32% | Upgrade
|
| Payout Ratio | 65.83% | 24.70% | - | 77.99% | 85.71% | 110.57% | Upgrade
|
| Buyback Yield / Dilution | 1.52% | -0.13% | -0.06% | -2.80% | -16.71% | -4.24% | Upgrade
|
| Total Shareholder Return | 3.55% | 2.46% | -0.06% | -1.19% | -15.65% | -3.93% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.